The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 15.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 49%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (10 analysts) rates it buy, with a mean price target of $132.
Cameco Corp CCJ
Clears both ethical standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Cameco Corporation provides uranium for the generation of electricity in the Americas, Europe, and Asia.
read at $93.62
Cameco Corp holds its Accumulation at $93.62.
- PHPhase · the trend structure carries the Accumulation label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · passes the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Accumulation |
| Quantitative state | The statistical read favours the sellers, held for 17 days |
| Price | $93.62 |
| Valuation | 161.41 trailing · 49.90 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 0.99 |
The opportunity · what the numbers say it is worth
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish — a quality-at-a-fair-price name rather than a deep-value one.
| Revenue growth | -7.20% |
| Profit margin | 10.21% |
| Debt to equity | 17.13 |
| Analyst consensus | Buy · 11 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company clears both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. Here is how it did on each:
Used by most halal investing apps ✓ PASSES
The one Titan applies ✓ PASSES
What these two standards are, and how they differ →
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Debt load Interest-bearing debt is just 9.7% of its assets, well under the one-third ceiling — it does not run on borrowed money. Pass
- Interest-bearing cash Cash held in interest-bearing accounts and securities is 1.0% of assets, under the one-third limit. Pass
- Receivables Money owed to the company is 14.1% of assets, under the 49% limit. Pass
- Revenue purity Only 0.7% of revenue comes from non-compliant sources — under the 5% line. Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Uranium supplier priced for perfect conditions
Picture a miner selling fuel to power stations across three continents. Demand for uranium edges higher as grids chase low-carbon electricity, yet Cameco still only grows revenue at 7 percent a year while posting an 18 percent profit margin and 10 percent return on equity.
We pass. The shares sit at 85.62 dollars against our fair value of 75.20 dollars, a forward multiple of 45 times earnings, and only a narrow moat to protect returns. In a cyclical industry that valuation already prices in the best possible outcome.
The real danger is the classic trap. Uranium prices swing hard with reactor build cycles and policy shifts. When the cycle turns, peak earnings collapse faster than multiples can expand, leaving holders with both lower profits and a re-rated stock. Ethical screen cleared, but the numbers still do not add up.
Analysis, not advice.
| Forward P/E | 49.9x expensive — the price assumes strong growth ahead |
| Trailing P/E | 161.4x expensive — the price assumes strong growth ahead |
| Revenue growth | -7.2% revenue is shrinking |
| Profit margin | 10.2% thin but positive margins |
| Return on equity | 5.1% a modest return on shareholder capital |
| Debt to equity | 0.17 minimal debt — a conservative balance sheet |
| Current ratio | 3.06 comfortably covers its short-term bills |
| Beta | 0.99 steadier than the market |
| Market cap | $40.8B |
The risks · The things to watch: its business and earnings are exposed to Canada and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on CCJ
- › Skyharbour, Purecore sign LoI for Yurchison uranium option Mining Technology · 30d ago
- › MP Materials and the U.S. Rare Earth Push are Starting to Align Zacks · 16 Jul 2026
- › Purepoint Uranium CEO: Canada and the US face the same uranium challenge Proactive · 15 Jul 2026
- › Cameco Resolves Cigar Lake Disruption: Are 2026 Targets on Track? Zacks · 15 Jul 2026
- › As the Iran War Resumes, 2 Energy ETFs Ride Oil’s Renewed Rally MarketBeat · 15 Jul 2026
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in CCJ's space worth a look
Screened names in the same industry · explore each on its own page.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 49%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (10 analysts) rates it buy, with a mean price target of $132.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The political ledger · congressional disclosures
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 7 May2024 | Tommy Tuberville | Republican | buy | 1K–15K |
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $120.14 | -21.1% | · | $789 | -21.1% |
| 2 months | $116.04 | -18.3% | · | $817 | -18.3% |
| 3 months | $115.30 | -17.8% | · | $822 | -17.8% |
| 6 months | $95.74 | -1.0% | · | $990 | -1.0% |
| 1 year | $63.71 | +48.8% | $0.17 | $1,491 | +49.1% |
| 2 years | $53.39 | +77.6% | $0.29 | $1,781 | +78.1% |
| 3 years | $30.58 | +210.0% | $0.37 | $3,113 | +211.3% |
| 5 years | $21.14 | +348.5% | $0.53 | $4,510 | +351.0% |
Historical returns from market close data. Past performance does not guarantee future results.